Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ IRF4 Antibody Blocking Peptide
SDP

Catalog No. NBP176574E
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP176574E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP176574E Supplier Novus Biologicals™ Supplier No. NBP176574PEP

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 16 amino acids near the carboxy terminus of human IRF4. Source: Synthetic (Accession #: NP_002451) The IRF4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 3662
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76574. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias interferon regulatory factor 4, IRF-4, LSIRFMUM1, Lymphocyte-specific interferon regulatory factor, Multiple myeloma oncogene 1, NF-EM5
Gene Symbol IRF4
Product Type IRF4
Quantity 0.05 mg
Regulatory Status RUO
Source Synthetic
Termination 16 amino acids near the carboxy terminus of human IRF4
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.